Timothy Vartanian

Timothy Vartanian

Cornell University

H-index: 45

North America-United States

About Timothy Vartanian

Timothy Vartanian, With an exceptional h-index of 45 and a recent h-index of 23 (since 2020), a distinguished researcher at Cornell University, specializes in the field of Multiple Sclerosis, Biology of the Newly Forming MS Lesion, Environmental Triggers, Remyelination and Myelin Repair, Innate Immu.

His recent articles reflect a diverse array of research interests and contributions to the field:

One-Year Analysis of Efficacy and Safety Data From Black/African American and Hispanic/Latino People With Relapsing Multiple Sclerosis Receiving Ocrelizumab Treatment in the …

Validated, Quantitative, Machine Learning-Generated Neurologic Assessment of Multiple Sclerosis Using a Mobile Application

Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial

Clostridium perfringens Epsilon Toxin Binds to and Kills Primary Human Lymphocytes

Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients

Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege

An Interim Analysis of Efficacy and Safety Data in Black and Hispanic Patients With Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial (S31. 006)

Effect of RIPK1 Inhibitor, SAR443820, on Serum Neurofilament Light Levels in Patients with Multiple Sclerosis: A Phase 2 Trial Design (P6-3.011)

Timothy Vartanian Information

University

Position

Professor, Brain and Mind Research Institute, Weill Cornell Medical College

Citations(all)

10878

Citations(since 2020)

2105

Cited By

9520

hIndex(all)

45

hIndex(since 2020)

23

i10Index(all)

66

i10Index(since 2020)

44

Email

University Profile Page

Google Scholar

Timothy Vartanian Skills & Research Interests

Multiple Sclerosis

Biology of the Newly Forming MS Lesion

Environmental Triggers

Remyelination and Myelin Repair

Innate Immu

Top articles of Timothy Vartanian

One-Year Analysis of Efficacy and Safety Data From Black/African American and Hispanic/Latino People With Relapsing Multiple Sclerosis Receiving Ocrelizumab Treatment in the …

2024/4/16

Timothy Vartanian
Timothy Vartanian

H-Index: 25

Juan Acosta
Juan Acosta

H-Index: 4

Validated, Quantitative, Machine Learning-Generated Neurologic Assessment of Multiple Sclerosis Using a Mobile Application

International Journal of MS Care

2024/3/1

Timothy Vartanian
Timothy Vartanian

H-Index: 25

Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial

Journal of drugs in dermatology: JDD

2020/6/1

Clostridium perfringens Epsilon Toxin Binds to and Kills Primary Human Lymphocytes

Toxins

2023/6/29

Timothy Vartanian
Timothy Vartanian

H-Index: 25

Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients

2023/5/5

Timothy Vartanian
Timothy Vartanian

H-Index: 25

Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege

The Journal of clinical investigation

2023/5/1

An Interim Analysis of Efficacy and Safety Data in Black and Hispanic Patients With Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial (S31. 006)

2023/4/25

Timothy Vartanian
Timothy Vartanian

H-Index: 25

Juan Acosta
Juan Acosta

H-Index: 4

Effect of RIPK1 Inhibitor, SAR443820, on Serum Neurofilament Light Levels in Patients with Multiple Sclerosis: A Phase 2 Trial Design (P6-3.011)

2023/4/25

Epsilon toxin-producing Clostridium perfringens colonize the MS gut and epsilon toxin overcomes immune privilege

J Clin Invest

2023/2/28

Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment

Brain Communications

2023

System and method for remote diagnosis of disease progression

2022/9/20

Antigen presenting group 3 innate lymphoid cells orchestrate neuroinflammation

The Journal of Immunology

2021/5/1

Machine Learning Evaluation of Multiple Sclerosis Patients During the Time of COVID-19 (4749)

2021/4/13

Timothy Vartanian
Timothy Vartanian

H-Index: 25

Antigen-presenting innate lymphoid cells orchestrate neuroinflammation

Nature

2021/12/23

Treating minority patients with multiple sclerosis: Development of the CHIMES trial

annual meeting of the Consortium of Multiple Sclerosis Centers

2021/10/25

Timothy Vartanian
Timothy Vartanian

H-Index: 25

Juan Acosta
Juan Acosta

H-Index: 4

A multi-ligand imaging study exploring GABAergic receptor expression and inflammation in multiple sclerosis

Molecular imaging and biology

2020/12

In vivo Blood-brain Barrier Permeability Assays Using Clostridium perfringens Epsilon Toxin

Bio-protocol

2020/8/5

Timothy Vartanian
Timothy Vartanian

H-Index: 25

Impact of lesion location on longitudinal myelin water fraction change in chronic multiple sclerosis lesions

Journal of Neuroimaging

2020/7

Automated EDSS scoring using a mobile App and Machine learning.(2631)

Neurology

2020/4/14

Timothy Vartanian
Timothy Vartanian

H-Index: 25

See List of Professors in Timothy Vartanian University(Cornell University)

Co-Authors

academic-engine